Merck Shares Are Trading Higher After the Company Along With Ridgeback Biotherapeutics Initiated Phase 3 of the MOVe-NOW Trial to Evaluate Lagevrio.
Merck Shares Are Trading Higher After the Company Along With Ridgeback Biotherapeutics Initiated Phase 3 of the MOVe-NOW Trial to Evaluate Lagevrio.
默沙東股價上漲，該公司與Ridgeback Biotherapeutics共同啓動了MOVe-NOW試驗的3期，以評估Lagevrio。
Merck Shares Are Trading Higher After the Company Along With Ridgeback Biotherapeutics Initiated Phase 3 of the MOVe-NOW Trial to Evaluate Lagevrio.
默沙東股票上漲，因爲該公司與Ridgeback Biotherapeutics共同啓動了MOVe-NOW試驗的第三階段，以評估Lagevrio。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
資訊熱榜
更新時間